AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 3527523
Drug: Human ultralente
RxNorm normalized name: INSULIN HUMAN ULTRALENTE 100 UNIT/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Human ultralente insulin
Trial: 16914369
Drug: Aspirin 325
RxNorm normalized name: aspirin 325 MG
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin 325 mg/day
Trial: 2212374
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate (mean 27.5 mg) administered three times daily for at least 2 weeks
Trial: 16860171
Drug: 20 mg/d
RxNorm normalized name: Valtoco, 20 mg/dose nasal spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg/d olanzapine for 20 days (group A, n=12)
Trial: 28152989
Drug: SQ-LNS with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SQ-LNS with 0, 5 or 10 mg zinc, 6 mg iron, and 400 μg vitamin A, along with malaria and diarrhea treatment.
Trial: 28152989
Drug: SQ-LNS with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SQ-LNS with 10 mg zinc.
Trial: 3047214
Drug: Ranitidine 300
RxNorm normalized name: ranitidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 300 mg
Trial: 9022602
Drug: Estrogen therapy
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen therapy in hypertensive women
Trial: 15715103
Drug: Radiotherapy in
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Radiotherapy in conjunction with roentgeno‐endovascular occlusion of the internal ileal arteries and/or regional chemotherapy
Trial: 17300593
Drug: Vildagliptin 100
RxNorm normalized name: vildagliptin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vildagliptin 100 mg q.d. + Pioglitazone 30 mg q.d. (100/30 mg q.d.)
Trial: 17300593
Drug: Vildagliptin 100
RxNorm normalized name: vildagliptin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vildagliptin 100 mg q.d. (monotherapy)
Trial: 10401948
Drug: Inspiratory Pressure
RxNorm normalized name: inspiratory pressure threshold loading device
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inspiratory Pressure Support (IPS) > 5 cm H2O in low ventilation group (10 l/min)
Trial: 10401948
Drug: Automatic Tube
RxNorm normalized name: Sus scrofa fallopian tube preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Automatic Tube Compensation (ATC) in high ventilation group (> 10 l/min)
Trial: 19255890
Drug: Olive oil
RxNorm normalized name: Olive Oil
DrugBank: Olive oil (DB09567)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olive oil (placebo) capsules
Trial: 6528959
Drug: Theo-Dur, 300
RxNorm normalized name: Theo-Dur, 300 mg oral tablet, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theo-Dur, 300 mg twice daily
Trial: 2196145
Drug: Pentoxifylline 200
RxNorm normalized name: pentoxifylline 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentoxifylline 200 mg
Trial: 30465175
Drug: Acotiamide 300
RxNorm normalized name: acetiamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acotiamide 300 mg/day for 2 weeks
Trial: 24916552
Drug: Sugar equivalent
RxNorm normalized name: Invert Sugar
DrugBank: Invert sugar (DB09344)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sugar equivalent component in ice cream
Trial: 16826054
Drug: Low-dose group
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose group (10 MU/0.1 mL saline)
Trial: 30576842
Drug: Multi-faceted intervention
RxNorm normalized name: Parasedge Multi
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multi-faceted intervention to improve adherence to P2Y12 inhibitors
Trial: 24637559
Drug: Low-dose sildenafil
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose sildenafil
Trial: 11800303
Drug: Oral artesunate
RxNorm normalized name: Artesunate
DrugBank: Artesunate (DB09274)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Oral artesunate 2 mg/kg as the first dose, 1 mg/kg every 12 hours orally for at least 5 days together with split doses of mefloquine, 15 mg/kg and 6 hours later 10 mg/kg orally 1 day after artesunate was stopped (group II)
Trial: 2280168
Drug: Irlen filter
RxNorm normalized name: FILTER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irlen filter treatment group (n = 11)
Trial: 26119285
Drug: Cream with
RxNorm normalized name: CREAM WITH APPLICATOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cream with aqueous extract from leaf of five-leaf serratula containing 2.51% of arbutin applied twice a day for 8 weeks
Trial: 16443418
Drug: Intravenous hydration
RxNorm normalized name: Chloral Hydrate
DrugBank: Chloral hydrate (DB01563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous hydration for 12 hours before contrast exposure, followed by hemofiltration for 18 to 24 hours after contrast exposure (post‐hemofiltration group; n = 31)
Trial: 16443418
Drug: Intravenous hydration
RxNorm normalized name: Chloral Hydrate
DrugBank: Chloral hydrate (DB01563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous hydration with isotonic saline (1 mL x kg x h for 12 hours before and after contrast exposure, control group; n = 30)
Trial: 29362255
Drug: Home exercise
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Home exercise programme using Physitrack (online exercise prescription tool) for 8 weeks
Trial: 17912104
Drug: Biotène Oral
RxNorm normalized name: BIOTENE
DrugBank: Sodium fluorophosphate (DB09484)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biotène Oral Balance gel and toothpaste used daily
Trial: 23052751
Drug: Enhanced recovery
RxNorm normalized name: Chem-Star Recover
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enhanced recovery protocols including early laparoscopic cholecystectomy, restrictive endoscopic intervention, and early oral nutrition
Trial: 12809836
Drug: Colchicine 0.6
RxNorm normalized name: colchicine 0.6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colchicine 0.6 mg p.o. t.i.d. for 4 weeks
Trial: 10397378
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of 600 mg clomethiazole edisylate
Trial: 10397378
Drug: Rectal administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rectal administration of 600 mg clomethiazole edisylate
Trial: 21664710
Drug: Low-dose arms
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose arms (24Gy for indolent NHL and 30Gy for aggressive NHL)
Trial: 31740427
Drug: Novel treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Novel treatment (specifics not provided)
Trial: 2979691
Drug: Ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine 150 mg at night
Trial: 6441815
Drug: Cimetidine 400
RxNorm normalized name: cimetidine 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 400 mg at night
Trial: 1550148
Drug: Prostaglandin E2
RxNorm normalized name: Prostaglandin E2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Prostaglandin E2 in a controlled-release vaginal pessary
Trial: 16960155
Drug: Daily multivitamin
RxNorm normalized name: DAILY MULTIVITAMIN TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily multivitamin supplementation (5 mg folic acid, 50 mg pyridoxine, and 0.4 mg cyanocobalamin)
Trial: 1892032
Drug: Barium sulfate
RxNorm normalized name: Barium Sulfate
DrugBank: Barium (DB12481)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Barium sulfate (600-900 ml orally and 400 ml rectally)
Trial: 28797450
Drug: Early tube
RxNorm normalized name: Sus scrofa fallopian tube preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early tube feeding prior to treatment
Trial: 25836351
Drug: 30-month treatment
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 30-month treatment with fluticasone (500 μg bid)
Trial: 16595218
Drug: Luteinizing hormone
RxNorm normalized name: LUTEINIZING HORMONE
DrugBank: Luteinizing hormone (DB14741)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Luteinizing hormone (LH) surge group
Trial: 25428566
Drug: Paraffin bath
RxNorm normalized name: Paraffin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paraffin bath therapy with wrist orthosis
Trial: 9096989
Drug: Simvastatin, 20
RxNorm normalized name: Simvastatin, 20 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin, 20 mg daily, titrated up to 40 mg daily
Trial: 19545680
Drug: Cordyceps sinensis
RxNorm normalized name: CORDYCEPS SINENSIS
DrugBank: Ophiocordyceps sinensis (DB19288)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cordyceps sinensis (CS) 1.0 g 3 times a day
Trial: 10686270
Drug: Ketamine hydrochloride
RxNorm normalized name: Ketamine Hydrochloride
DrugBank: Ketamine (DB01221)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketamine hydrochloride (.5 mg/kg)
Trial: 26156737
Drug: 50 μg
RxNorm normalized name: penicillin G 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 μg vitamin D₃/d
Trial: 10779419
Drug: BFM treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BFM treatment with cranial irradiation
Trial: 20628590
Drug: Non-ACEi therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-ACEi therapy
Trial: 30654808
Drug: Artemether (AM)
RxNorm normalized name: Artemether
DrugBank: Artemether (DB06697)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Artemether (AM) 1.7 mg/kg and lumefantrine (LUM) 12 mg/kg twice daily for 3 days
Trial: 12844250
Drug: Dexamethasone (Dex)
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone (Dex) 8 mg administered on days 2-4 after chemotherapy
Trial: 11783280
Drug: Jiakang Ning
RxNorm normalized name: Scrophularia ningpoensis root extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Jiakang Ning (JKN) with low dose Tapazol
Trial: 18334909
Drug: Iloperidone 24
RxNorm normalized name: Iloperidone
DrugBank: Iloperidone (DB04946)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Iloperidone 24 mg/d and Ziprasidone 160 mg/d
Trial: 6140699
Drug: Ethanol 0.4
RxNorm normalized name: ethanol 0.4 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol 0.4 g/kg
Trial: 21670177
Drug: Crushed tablet
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crushed tablet
Trial: 18811878
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (FP), 500 microg twice daily
Trial: 9026280
Drug: Long protocol
RxNorm normalized name: long pepper extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long protocol with GnRH agonist in depot formula
Trial: 14997006
Drug: Anakinra therapy
RxNorm normalized name: anakinra
DrugBank: Anakinra (DB00026)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Anakinra therapy
Trial: 8008325
Drug: Erythromycin, 500
RxNorm normalized name: Erythromycin, 500 mg oral delayed release tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin, 500 mg orally four times a day for 7 days (initial dosage)
Trial: 8008325
Drug: Erythromycin, 250
RxNorm normalized name: Erythromycin, 250 mg oral delayed release tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin, 250 mg orally four times a day (adjusted dosage)
Trial: 28093533
Drug: Deworming intervention
RxNorm normalized name: oxfendazole
DrugBank: Oxfendazole (DB11446)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deworming intervention with 400 mg of albendazole and educational training about STH infection, treatment, and prevention, conducted twice (May 2013 and November 2013)
Trial: 26213879
Drug: Analgesic administration
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Analgesic administration with massage
Trial: 24721481
Drug: 30-minute computerized
RxNorm normalized name: TAGETES MINUTA FLOWER OIL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30-minute computerized brief motivational intervention (C‐BMI) plus access to free nicotine replacement therapy (NRT)
Trial: 1957836
Drug: Flavone acetic
RxNorm normalized name: flavone
DrugBank: Flavone (DB07776)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flavone acetic acid (FAA) at 5,120 and 6,144 mg/m2 as 3-hour intravenous infusions
Trial: 7223659
Drug: 160 mg
RxNorm normalized name: nadolol 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 160 mg slow release oxprenolol, once daily
Trial: 1107090
Drug: 1% hydrocortisone
RxNorm normalized name: HYDROCORTISONE 0.01 g in 1 g TOPICAL OINTMENT [AFASSCO 1% Hydrocortisone]
DrugBank: Hydrocortisone (DB00741)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: 1% hydrocortisone in a stabilized 10% urea cream
Trial: 12048631
Drug: Medical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical treatment (n = 46)
Trial: 8004302
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of 15 ppm NO in air
Trial: 27197662
Drug: FEX 60
RxNorm normalized name: Wal-Fex 60 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FEX 60 mg with 150 mL of AJ
Trial: 8836275
Drug: Nebulized tetracaine
RxNorm normalized name: Tetracaine
DrugBank: Tetracaine (DB09085)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nebulized tetracaine 0.5 mg/kg
Trial: 12815350
Drug: 6-degree taper
RxNorm normalized name: CAPER BERRY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6-degree taper
Trial: 6666227
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg ISDN sustained-release, three times a day
Trial: 19597031
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of tamoxifen and fenretinide
Trial: 1576071
Drug: Nicotinic acid
RxNorm normalized name: Nicotinic acid
DrugBank: Niacin (DB00627)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotinic acid (1 g three times daily)
Trial: 3797019
Drug: Self-efficacy expectancies
RxNorm normalized name: corticotropin
DrugBank: Corticotropin (DB01285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-efficacy expectancies and pain tolerance times at treatment
Trial: 31452081
Drug: Extended interval
RxNorm normalized name: Minerval
DrugBank: Idroxioleic acid (DB18213)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended interval dosing (EID) of natalizumab (MDI 6.2 weeks)
Trial: 27449661
Drug: More intensive
RxNorm normalized name: polyurethane-35 (not more than MPA.S at 40 %)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: More intensive RRT (hemodialysis or sustained low‐efficiency dialysis six times per week or continuous venovenous hemodiafiltration at 35 ml/kg per hour)
Trial: 9299805
Drug: BIGCBT without
RxNorm normalized name: threonine
DrugBank: Threonine (DB00156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: BIGCBT without medication
Trial: 3091405
Drug: Clomiphene citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate (50 mg)
Trial: 20949263
Drug: Non-fixed dose
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-fixed dose combination (Arsuamoon AS 50 mg and Flavoquine AQ 200 mg)
Trial: 31927548
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of serum cystatin C (sCysC) and urinary N-Acetyl-Beta-D-glucosaminidase (uNAG)
Trial: 9253339
Drug: T4 treatment
RxNorm normalized name: T4
DrugBank: Levothyroxine (DB00451)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: T4 treatment (L-thyroxine) at a mean dose of 2.8 +/- 0.9 micrograms/kg (0.192 +/- 0.058 mg/day) for a mean duration of 9.2 +/- 5.4 yr
Trial: 25398701
Drug: Antidepressant
RxNorm normalized name: Antidepressant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressant
Trial: 31628475
Drug: Normal Nicotine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Normal Nicotine Content (NNC) cigarettes (15.8 mg nicotine per g tobacco)
Trial: 20626209
Drug: Mycophenolate mofetil
RxNorm normalized name: Mycophenolate Mofetil
DrugBank: Mycophenolate mofetil (DB00688)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mycophenolate mofetil (1 g twice daily)
Trial: 7670428
Drug: Cognitive-behavioral treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral treatment (5-week duration including relaxation training, self-monitoring of stressors, and cognitive coping strategies)
Trial: 1847127
Drug: Induction regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction regimen of external beam radiotherapy to the liver (21.0 Gy, 3.0 Gy/Fx, 10 MV photons, 4 days per week) with low-dose chemotherapy (5-Fluorouracil (FU), 500 mg, i.v.; Doxorubicin, 15 mg, i.v.) on treatment Days 1, 3, 5 and 7.
Trial: 2894883
Drug: Fixed combination
RxNorm normalized name: Progestogens and estrogens, fixed combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed combination of atenolol 50 mg and nifedipine 20 mg once daily for eight weeks
Trial: 17371886
Drug: Alendronate, 70
RxNorm normalized name: Alendronate, 70 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate, 70 mg once weekly
Trial: 8217176
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg of ondansetron
Trial: 28215835
Drug: Early endoscopic
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early endoscopic treatment (ET) with prophylaxis until resolution
Trial: 7670399
Drug: Detection of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Detection of malignant B cells in PBSC samples after chemotherapy
Trial: 27175292
Drug: Methotrexate (MTX)
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate (MTX) monotherapy
Trial: 25375075
Drug: Coenzyme Q10
RxNorm normalized name: Coenzyme Q10
DrugBank: Ubidecarenone (DB09270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Coenzyme Q10 supplementation (50 mg twice daily)
Trial: 7674143
Drug: Higher doses
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher doses and concentrations of SH/TA-508
Trial: 21707327
Drug: Testosterone gel
RxNorm normalized name: Androgel 1.62% Metered Dose Pump Testosterone Gel
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone gel
Trial: 29505863
Drug: Vehicle control
RxNorm normalized name: meningococcal group B vaccine / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle Prefilled Syringe [Bexsero]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vehicle control cream
Trial: 28609362
Drug: Everolimus with
RxNorm normalized name: Everolimus
DrugBank: Everolimus (DB01590)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Everolimus with concomitant octreotide treatment
Trial: 20677963
Drug: Orthodontic oral
RxNorm normalized name: monofluorophosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orthodontic oral appliance (orthodontic OA)
Trial: 7261830
Drug: Bethanechol 25
RxNorm normalized name: bethanechol 25 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bethanechol 25 mg 4 times a day
Trial: 27835765
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine 300U/mL (Gla-300)
Trial: 18335329
Drug: Clomiphene citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate (CC) 50 mg on days 3-5
Trial: 11070759
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate 20 mg-SR
Trial: 20949341
Drug: Morphine sulfate
RxNorm normalized name: Morphine Sulfate
DrugBank: Morphine (DB00295)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Morphine sulfate and naltrexone hydrochloride extended release capsules taken intact with water under fed conditions
Trial: 11435270
Drug: Long-term antipsychotic
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term antipsychotic treatment
Trial: 17619791
Drug: Short-acting beta2
RxNorm normalized name: Short-acting sulfonamides
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short-acting beta2 agonists as needed
Trial: 15557857
Drug: Timolol maleate
RxNorm normalized name: Timolol Maleate
DrugBank: Timolol (DB00373)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Timolol maleate gel-forming solution
Trial: 11573708
Drug: Antiarrhythmic drugs
RxNorm normalized name: ANTIARRHYTHMICS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiarrhythmic drugs